Trouble reading this email? View it in your browser
European Federation of Pharmaceutical industries and associations

EFPIA Newsletter 7 July 2022


EU pharma in numbers: a portrait of an industry at a crossroads

Learn more

"The Pharmaceutical Industry in Figures report is a snapshot in time. It tells us where we are today but says nothing about the future. (...) The information contained in the 2022 report, together with trend data over recent years and international comparison data can be used to inform the urgent discussions we need to have about Europe’s place in a competitive world and how pharma can contribute both to health and wealth in a key moment for policy development on the continent" says Nathalie Moll, EFPIA Director General.

Read more




EFPIA statement on European Council decision on membership applications from Ukraine and Moldova...
24 June 2022

Read more




Improving sustainable patient access to oncology combination therapies in Europe: a trade association...
01 July 2022 - Veronica Calzada

Challenges that can be solved if shared by all stakeholders Read more

#WeWontRest until patients everywhere can see the results of innovation in black and white...
29 June 2022 - Andy Powrie-Smith

Innovation is not an abstract concept, it transforms the lives of patients. It means new experiences, moments shared... Read more

Landmark moment for Innovative Health Initiative (IHI)
28 June 2022 - Magda Chlebus

IHI’s first calls for proposals present an unprecedented opportunity to tackle key EU priorities and unmet medical need... Read more


#WeWontRest until patients everywhere can see the results of innovation, in black and white


What we are reading


Supporting patients in a war zone
On 30 June 2022 (GOLD)

How has the pharmaceutical industry and its relevant organisations responded to create healthcare continuity and prevent... Read more

The research-based pharmaceutical industry has a vision for a healthier future for Europe.
On 24 June 2022 (Lilly)

By Nathalie Moll, EFPIA Director General. Read more

Europe faces choice between innovation or the risk of stagnation, writes Bernard Mallee
On 22 June 2022 (IPHA)

A quarter of a century ago, almost half of global new treatments originated in Europe. Today, the proportion has dropped... Read more